Hongzhao Qi
- Molecular Biology top 5%
- Cancer Research top 2%
- Biomedical Engineering top 10%
- Biomaterials top 5%
- Immunology
- Topics
- RNA Interference and Gene Delivery (14 papers)MicroRNA in disease regulation (14 papers)Nanoparticle-Based Drug Delivery (14 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Hongzhao Qi
51 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Molecular Biology 1.5k
- Cancer Research 745
- Biomedical Engineering 467
- Biomaterials 324
- Immunology 180
Countries citing papers authored by Hongzhao Qi
This map shows the geographic impact of Hongzhao Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongzhao Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongzhao Qi more than expected).
Fields of papers citing papers by Hongzhao Qi
This network shows the impact of papers produced by Hongzhao Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongzhao Qi. The network helps show where Hongzhao Qi may publish in the future.
Co-authorship network of co-authors of Hongzhao Qi
This figure shows the co-authorship network connecting the top 25 collaborators of Hongzhao Qi. A scholar is included among the top collaborators of Hongzhao Qi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongzhao Qi. Hongzhao Qi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 9 | |
| 5 | 2 | |
| 6 | 9 | |
| 7 | 68 | |
| 8 | 40 | |
| 9 | 41 | |
| 10 | 19 | |
| 11 | 41 | |
| 12 | 38 | |
| 13 | 45 | |
| 14 | 17 | |
| 15 | 15 | |
| 16 | 25 | |
| 17 | 32 | |
| 18 | 110 | |
| 19 | 10 | |
| 20 | 52 |
About Hongzhao Qi
Hongzhao Qi is a scholar working on Cancer Research, Biomaterials and Business and International Management, having authored 52 papers that have together received 2.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), MicroRNA in disease regulation (14 papers) and Nanoparticle-Based Drug Delivery (14 papers). The work is most often cited by research in Cancer Research (745 citations), Biomaterials (324 citations) and Molecular Biology (1.5k citations). Hongzhao Qi has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Xubo Yuan, Peifeng Li, Jin Zhao, Xin Hou, Chunsheng Kang, Chaoyong Liu, Tao Yu, Yanyan Yang, Xiuxiu Fu and Tianxiang Li. Their work appears in journals such as Advanced Materials, ACS Nano and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.